PIK3CA mutation in a case of CTNNB1-mutant sinonasal glomangiopericytoma

Cold Spring Harb Mol Case Stud. 2022 Jan 10;8(1):a006120. doi: 10.1101/mcs.a006120. Print 2022 Jan.

Abstract

Glomangiopericytomas are rare, primary sinonasal tumors. The existing literature is mostly limited to reports describing the clinicopathologic characteristics of these tumors. Comprehensive genetic characterization of glomangiopericytomas remains lacking. Whole-exome sequencing of a case of glomangiopericytoma was performed under an institutional review board-approved protocol. A 69-yr-old female underwent surgical resection of a glomangiopericytoma. Whole-exome sequencing revealed somatic mutations in CTNNB1 and PIK3CA, the former previously associated with this pathology but the latter not described. Concurrent dysregulation of Wnt/β-catenin and PI3K/AKT/mTOR signaling, secondary to mutations in these two oncogenes, may be amenable to targeted treatment with existing clinically approved drugs. Genomic characterization of glomangiopericytomas remains lacking. This study reports novel coexistence of PIK3CA and CTNNB1 mutations in a case of glomangiopericytoma that may offer insight into the pathogenesis and potential for targeted medical therapies of this rare tumor.

Keywords: thick skull base.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Class I Phosphatidylinositol 3-Kinases* / genetics
  • Female
  • Glomus Tumor / genetics*
  • Humans
  • Mutation
  • Oncogenes
  • beta Catenin* / genetics

Substances

  • CTNNB1 protein, human
  • beta Catenin
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human